Effect of nevirapine, efavirenz and lopinavir/ritonavir on the therapeutic concentration and toxicity of lumefantrine in people living with HIV at Lagos University Teaching Hospital, Nigeria

• Main Authors: Sikiru Olatunji Usman (Author), Ibrahim Adekunle Oreagba (Author), Akinwumi Akinyinka Akinyede (Author), Esther Oluwatoyin Agbaje (Author), Moshood Olusola Akinleye (Author), Adaobi Goodness Onwujuobi (Author), Chioma Ken-Owotor (Author), Olatunbosun Adeuja (Author), Tosin Ogunfowokan (Author), Segun Kogbe (Author), Emmanuel Tope Owolabi (Author), Hannah Adeniji (Author), Abdul Wasiu Busari (Author), Olayinka Olayiwola Hassan (Author), Ganiu Abideen (Author), Alani Sulaimon Akanmu (Author)
• Format: Book
• Published: Elsevier, 2020-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Patients living with HIV in malarial endemic regions may experience clinically significant drug interaction between antiretroviral and antimalarial drugs. Effects of nevirapine (NVP), efavirenz (EFV) and lopinavir/ritonavir (LPVr) on lumefantrine (LM) therapeutic concentrations and toxicity were eva...